Literature DB >> 9864197

Novel target antigens of the variant-specific immune response to Plasmodium falciparum identified by differential screening of an expression library.

C Le Scanf1, T Fandeur, S Bonnefoy, M Guillotte, O Mercereau-Puijalon.   

Abstract

A primary infection by the Plasmodium falciparum Palo Alto O and R antigenic variants induces a variant-specific immunity in the Saimiri sciureus monkey. We have shown that these variants express distinct PfEMP1 antigens and differ in their levels of expression of additional antigens, including two conserved erythrocyte membrane-associated proteins, HRP1 and PfEMP3. To identify the antigens eliciting a variant-specific response, we conducted a differential screening of a lambdagt11 library with variant-specific sera. We report here the analysis of the 46 anti-R-specific clones. Two specific targets of the anti-R response were identified: (i) PfEMP3, suggesting that immunogenicity of this antigen is modulated by its relative abundance in different variants, and (ii) Asn-rich motifs. Most anti-R-specific clones, derived from so-far-undescribed genes, were detected by a cross-reaction on poly(Asn) stretches, as indicated by elimination of the signal after absorption on Asn-rich sequences. Reverse transcription-PCR (RT-PCR) showed that expression of the gene defined by clone 13 was R specific. Pepscan analysis of clone 13 identified three Asn-rich polypeptides and one unique peptide reacting specifically with antibodies eluted from the R-infected erythrocyte surface. Antisera raised to the unique peptide reacted with an R-specific protein. Attempts to demonstrate that clone 13 was derived from a var gene by using PCRs combining clone 13 and var-derived primers were unsuccessful. The var genes expressed by O and R parasites were identified not by this strategy but by RT-PCR with var-specific primers. This work has provided novel insights into immunity to antigenic variants and has identified a novel gene switched on during antigenic variation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864197      PMCID: PMC96278     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  A modification in restriction pattern of the Plasmodium falciparum Pf60 multigene family associated with a specific antigenic variation switch in the Palo Alto line.

Authors:  C Le Scanf; B Carcy; S Bonnefoy; T Fandeur; O Mercereau-Puijalon
Journal:  Behring Inst Mitt       Date:  1997-03

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  An asparagine-rich protein from blood stages of Plasmodium falciparum shares determinants with sporozoites.

Authors:  H D Stahl; A E Bianco; P E Crewther; T Burkot; R L Coppel; G V Brown; R F Anders; D J Kemp
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

4.  The role of variant antigens in acquired immunity to Plasmodium falciparum.

Authors:  M Hommel
Journal:  Ann Soc Belg Med Trop       Date:  1985

5.  Expressed var genes are found in Plasmodium falciparum subtelomeric regions.

Authors:  R Hernandez-Rivas; D Mattei; Y Sterkers; D S Peterson; T E Wellems; A Scherf
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

Authors:  P C Bull; B S Lowe; M Kortok; C S Molyneux; C I Newbold; K Marsh
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

7.  Plaque antibody selection: rapid immunological analysis of a large number of recombinant phage clones positive to sera raised against Plasmodium falciparum antigens.

Authors:  L S Ozaki; D Mattei; M Jendoubi; P Druihle; T Blisnick; M Guillotte; O Puijalon; L P Da Silva
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

8.  A Plasmodium falciparum antigen containing clusters of asparagine residues.

Authors:  M Wahlgren; L Aslund; L Franzén; M Sundvall; B Wåhlin; K Berzins; L A McNicol; A Björkman; H Wigzell; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children.

Authors:  H Contamin; T Fandeur; C Rogier; S Bonnefoy; L Konate; J F Trape; O Mercereau-Puijalon
Journal:  Am J Trop Med Hyg       Date:  1996-06       Impact factor: 2.345

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  3 in total

1.  An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.

Authors:  Inès Vigan-Womas; Micheline Guillotte; Cécile Le Scanf; Sébastien Igonet; Stéphane Petres; Alexandre Juillerat; Cyril Badaut; Farida Nato; Achim Schneider; Anne Lavergne; Hugues Contamin; Adama Tall; Laurence Baril; Graham A Bentley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

2.  Relationship of binding of immunoglobulin G to Plasmodium falciparum-infected erythrocytes with parasite endemicity and antibody responses to conserved antigen in immune individuals.

Authors:  Antoine-Marie Diatta; Laurence Marrama; Adama Tall; Jean-François Trape; Alioune Dieye; Olivier Garraud; Odile Mercereau-Puijalon; Ronald Perraut
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  In vitro selection for adhesion of Plasmodium falciparum-infected erythrocytes to ABO antigens does not affect PfEMP1 and RIFIN expression.

Authors:  William van der Puije; Christian W Wang; Srinidhi Sudharson; Casper Hempel; Rebecca W Olsen; Nanna Dalgaard; Michael F Ofori; Lars Hviid; Jørgen A L Kurtzhals; Trine Staalsoe
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.